By Michael Erman and Sriparna Roy Oct 13 (Reuters) – Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday driven by strong sales of immune disease treatment Tremfya, and said
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 13 (Reuters) - Anlon Technology Solutions Ltd : * GETS CONTRACT WORTH 4.5 MILLION…
VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM MANCHESTER CITY MANAGER ENZO MARESCA AHEAD OF THEIR UEFA…
Oct 13 (Reuters) - Wall Street's investment banking and trading stalwarts posted an uneven third…
By Stephen Nellis NEW YORK, Oct 13 (Reuters) - Apple on Tuesday began showing off…
(Adds background, attempt to seek comment from Guilfoyle, paragraphs 3-6) By Jacob Bogage and Trevor…
VIDEO SHOWS: PRESS CONFERENCE WITH MANCHESTER CITY MANAGER ENZO MARESCA AHEAD OF CHAMPIONS LEAGUE MATCH…